The inactivation of eight different bacteria comprising Escherichia coli LMM1010 and MG1655, respectively a pressure-resistant strain and the corresponding wild-type, Salmonella Typhimurium, Pseudomonas fluorescens, Staphylococcus aureus, Enterococcus faecalis, Listeria innocua and Lactobacillus plantarum, by high hydrostatic pressure in skim milk supplemented with the lactoperoxidase-hydrogen peroxide-thiocyanate (LP) system at naturally occurring concentration was studied. In the absence of pressure treatment, the LP system had either no effect, i.e. on S. Typhimurium and E. coli LMM1010, a growth inhibiting effect, i.e. on E. coli MG1655, L. innocua, S. aureus, L. plantarum and E. faecalis, or a bactericidal effect, i.e. on P. fluorescens. The presence of the LP system affected inactivation by high pressure in a cell density-dependent manner. At low cell concentration (10(6) cfu/ml), the LP system strongly increased high-pressure inactivation as measured immediately after pressure treatment of all bacteria except the pressure-resistant E. coli. At high cell density (10(9) cfu/ml), only inactivation of L. innocua, E. faecalis and L. plantarum were enhanced. For both E. coli strains, the fate of the bacteria during 24 h following pressure treatment was also studied. It was found that in the presence of the LP system, considerable further inactivation occurred in the first hours after pressure treatment. The potential of the LP system to improve the bactericidal efficiency of high-pressure treatment for food preservation is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0168-1605(02)00263-5DOI Listing

Publication Analysis

Top Keywords

pressure treatment
16
high-pressure inactivation
8
coli lmm1010
8
presence system
8
inactivation
6
pressure
6
system
6
coli
5
treatment
5
lactoperoxidase system
4

Similar Publications

Background: Hypertension is a major global health issue. Aldosterone synthase inhibitors (ASIs) have emerged as a promising therapeutic strategy for blood pressure control.

Methods: A thorough search of the MEDLINE and Embase databases up to March 30, 2024, identified randomized trials comparing ASIs with a placebo for hypertension treatment.

View Article and Find Full Text PDF

Background: Elevated blood pressure (BP) prompts immediate emergency department (ED) visits instead of outpatient care, thus constituting a high-weight concern for the ED. This study investigated the short- and long-term outcomes of high BP patients in the ED.

Methods: A retrospective cohort study was conducted at King Abdulaziz University Hospital (KAUH), reviewing ED visits from January to December 2022.

View Article and Find Full Text PDF

Background:  Ultrasonographic measurement of optic nerve sheath diameter (ONSD) has been proposed as a non-invasive, bedside method to detect raised intracranial pressure (ICP) in various clinical settings. We aimed to correlate the ONSD obtained by ultrasonography (USG) with the ONSD obtained by magnetic resonance imaging (MRI) and to find its measurement accuracy.

Methodology:  A prospective double-blind study was carried out by performing ocular ultrasounds on 32 patients with clinical features of intracranial hypertension.

View Article and Find Full Text PDF

Background: This video article describes the use of bone-anchored prostheses for patients with transtibial amputations, most often resulting from trauma, infection, or dysvascular disease. Large studies have shown that about half of all patients with a socket-suspended artificial limb experience limited mobility and limited prosthesis use because of socket-related problems. These problems occur at the socket-residual limb interface as a result of a painful and unstable connection, leading to an asymmetrical gait and subsequent pelvic and back pain.

View Article and Find Full Text PDF

Implantable hemodynamic devices like the CardioMEMS HF System are commonly used to manage fluid status in patients with heart failure (HF) by measuring pulmonary pressures. Although CardioMEMS has been shown to reduce HF hospitalizations, rare complications (eg, device endothelialization) can occur and warrant clinical attention. A 67-year-old woman with HF with preserved ejection fraction and group 2 pulmonary hypertension experienced recurrent HF exacerbations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!